文献速递肝病

使用道路驾驶评估对肝硬化患者驾驶适应性的评价

The Assessment of Driving Fitness Using an On-Road Evaluation in Patients With Cirrhosis.
PubMed 文献 · Am J Gastroenterol · 2022-08-12

本研究前瞻性纳入2家三级肝病门诊的80例肝硬化患者,通过诊室内计算机驾驶评估(DriveABLE)和道路驾驶测试评价驾驶能力,并分析轻微肝性脑病(MHE)等与不安全驾驶的关联。仅2例(3%)在道路测试中被判为「不适合驾驶」,58%在DCAT中为不确定/失败,后者对应更多道路驾驶错误;高龄和MHE独立预测DCAT表现更差,但诊室工具不足以预测道路驾驶失败。

要点

  • 肝硬化患者中仅3%(2/80)在道路驾驶测试中被判不适合驾驶。
  • 58%的患者在DCAT中为不确定/失败,对应道路驾驶错误数更高。
  • MHE诊断不应单独用于限制肝硬化患者驾驶。

核心结论

  • 诊室测试表现更差与计算机驾驶评估电池评分更差及更多道路驾驶错误相关,但诊室工具不足以预测道路驾驶失败。
  • MHE诊断不应单独用于限制肝硬化患者驾驶,高危患者需在驾驶监管机构监督下进行道路驾驶测试。
  • 未来研究应继续改进和评估诊室或居家测试以预测驾驶表现。

研究设计与样本

  • 前瞻性研究,从2家三级肝病门诊招募患者,完成诊室测试及诊室和道路驾驶能力评估。
  • 共80例患者参与,平均年龄57岁,70%男性,75%为Child-Pugh B/C级,36%有显性肝性脑病病史。

主要发现

  • 30%的患者在心理测量肝性脑病评分和Stroop应用测试上均符合MHE标准。
  • 仅2例患者(3%)在道路驾驶测试中被判为「不适合驾驶」,其中1例有MHE,另1例无MHE。
  • 58%的患者在DCAT中被评为不确定/失败,该组平均道路驾驶错误数为5.3(SD 2.1),而DCAT通过组为4.2(SD 1.6),P=0.01。
  • 高龄(OR 1.3;CI 1.1,1.5;P=0.001)和经Stroop/心理测量肝性脑病评分诊断的MHE(OR 11.0;CI 2.3,51.8;P=0.002)独立预测DCAT表现更差。

关键数值与推荐

  • DCAT不确定/失败组平均道路驾驶错误数5.3(SD 2.1) vs DCAT通过组4.2(SD 1.6),P=0.01。
  • 高龄预测DCAT表现更差的OR为1.3(CI 1.1,1.5;P=0.001)。
  • MHE(Stroop/心理测量肝性脑病评分)预测DCAT表现更差的OR为11.0(CI 2.3,51.8;P=0.002)。

临床怎么用

  • 作者认为,MHE诊断不应单独用于限制肝硬化患者驾驶。
  • 作者指出,高危患者需要在驾驶监管机构监督下进行道路驾驶测试。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The association between cirrhosis and driving performance is of particular clinical relevance because of the life-threatening safety issues both for the driver with cirrhosis and the general public. Study aims were to assess (i) driving competency through the use of an in-office computerized battery and on-road driving assessment (DriveABLE) and (ii) the association between minimal hepatic encephalopathy (MHE), in-office paper-pencil tools, and additional measures (e.g., frailty, depression, cognitive testing) with unsafe driving. METHODS: Patients were prospectively recruited from 2 tertiary care liver clinics. In-office tests and in-office and on-road assessments of driving competence were completed. The χ 2 test and 1-way analysis of variance were used to analyze differences among those with and without MHE. Logistic regression was used to evaluate predictors of an indeterminate/fail result on the in-office computerized driving assessment battery (DriveABLE Cognitive Assessment Tool [DCAT]). RESULTS: Eighty patients participated with a mean age of 57 years, 70% male, 75% Child-Pugh B/C, and 36% with a history of overt hepatic encephalopathy. Thirty percent met MHE criteria on both the psychometric hepatic encephalopathy score and the Stroop app tests. Only 2 patients (3%) were categorized as "unfit to drive" in the on-road driving test, one with MHE and the other without. Fifty-eight percent of the patients were scored as indeterminate/fail on the DCAT. This corresponded to a higher mean number of on-road driving errors (5.3 [SD 2.1] vs 4.2 [SD 1.6] in those who passed the DCAT, P = 0.01). Older age (odds ratio 1.3; confidence interval 1.1, 1.5; P = 0.001) and MHE by Stroop/psychometric hepatic encephalopathy score (odds ratio 11.0; confidence interval 2.3, 51.8; P = 0.002) were independently predictive of worse performance on the DCAT. DISCUSSION: Worse performance in in-office testing was associated with worse scores on a computerized driving assessment battery and more on-road driving errors, but in-office tools were insufficient to predict on-road driving failures. A diagnosis of MHE should not be used alone to restrict driving in patients with cirrhosis. At-risk patients require on-road driving tests under the supervision of driving regulatory agencies. Future studies should continue to refine and evaluate in-office or at-home testing to predict driving performance.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Tandon P, Pidborochynski T, Abraldes JG, et al. The Assessment of Driving Fitness Using an On-Road Evaluation in Patients With Cirrhosis. Am J Gastroenterol. 2022. PMID: 36087105. doi:10.14309/ajg.0000000000001927

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。